Could a gut bacteria metabolite shield MS patients from relapses?

NCT ID NCT07318129

Recruiting now Disease control Sponsor: Glostrup University Hospital, Copenhagen Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 09, 2026 · Updated 17 times

Summary

This study tests whether a daily supplement called indole-3-propionic acid (IPA), a natural substance made by gut bacteria, can help people with relapsing-remitting multiple sclerosis (RRMS). Researchers will give IPA to 220 adults with RRMS and track whether it reduces relapses, brain lesions, and disability progression over 27 months. The goal is to see if boosting this gut-derived compound can protect against MS-related damage and improve metabolic health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Glostrup Hospital
RECRUITING

Glostrup Municipality, 2600, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)